496 related articles for article (PubMed ID: 15710236)
41. Long-term safety of GDNF gene delivery in the retina.
Wu WC; Lai CC; Chen SL; Sun MH; Xiao X; Chen TL; Lin KK; Kuo SW; Tsao YP
Curr Eye Res; 2005 Aug; 30(8):715-22. PubMed ID: 16109652
[TBL] [Abstract][Full Text] [Related]
42. Targeted retrograde gene delivery of brain-derived neurotrophic factor suppresses apoptosis of neurons and oligodendroglia after spinal cord injury in rats.
Nakajima H; Uchida K; Yayama T; Kobayashi S; Guerrero AR; Furukawa S; Baba H
Spine (Phila Pa 1976); 2010 Mar; 35(5):497-504. PubMed ID: 20190624
[TBL] [Abstract][Full Text] [Related]
43. Exogenous administration of glial cell line-derived neurotrophic factor improves recovery after spinal cord injury.
Kao CH; Chen SH; Chio CC; Chang CK; Lin MT
Resuscitation; 2008 Jun; 77(3):395-400. PubMed ID: 18367307
[TBL] [Abstract][Full Text] [Related]
44. Adenoviral GDNF gene transfer enhances neurofunctional recovery after recurrent laryngeal nerve injury.
Araki K; Shiotani A; Watabe K; Saito K; Moro K; Ogawa K
Gene Ther; 2006 Feb; 13(4):296-303. PubMed ID: 16251996
[TBL] [Abstract][Full Text] [Related]
45. Insulin-like growth factor 1 prevents neuronal cell death and paraplegia in the rabbit model of spinal cord ischemia.
Nakao Y; Otani H; Yamamura T; Hattori R; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jul; 122(1):136-43. PubMed ID: 11436046
[TBL] [Abstract][Full Text] [Related]
46. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
Popovic N; Maingay M; Kirik D; Brundin P
Exp Neurol; 2005 May; 193(1):65-74. PubMed ID: 15817265
[TBL] [Abstract][Full Text] [Related]
47. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
48. Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury.
Bakshi A; Shimizu S; Keck CA; Cho S; LeBold DG; Morales D; Arenas E; Snyder EY; Watson DJ; McIntosh TK
Eur J Neurosci; 2006 Apr; 23(8):2119-34. PubMed ID: 16630059
[TBL] [Abstract][Full Text] [Related]
49. Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells.
Rooney GE; McMahon SS; Ritter T; Garcia Y; Moran C; Madigan NN; Flügel A; Dockery P; O'Brien T; Howard L; Windebank AJ; Barry FP
Tissue Eng Part A; 2009 Oct; 15(10):3049-59. PubMed ID: 19335061
[TBL] [Abstract][Full Text] [Related]
50. Neuronal loss and expression of neurotrophic factors in a model of rat chronic compressive spinal cord injury.
Kasahara K; Nakagawa T; Kubota T
Spine (Phila Pa 1976); 2006 Aug; 31(18):2059-66. PubMed ID: 16915089
[TBL] [Abstract][Full Text] [Related]
51. Glial cell line-derived neurotrophic factor (GDNF) is required for differentiation of pontine noradrenergic neurons and patterning of central respiratory output.
Huang L; Guo H; Hellard DT; Katz DM
Neuroscience; 2005; 130(1):95-105. PubMed ID: 15561428
[TBL] [Abstract][Full Text] [Related]
52. Astrocytes infected with replication-defective adenovirus containing a secreted form of CNTF or NT3 show enhanced support of neuronal populations in vitro.
Smith GM; Hale J; Pasnikowski EM; Lindsay RM; Wong V; Rudge JS
Exp Neurol; 1996 May; 139(1):156-66. PubMed ID: 8635562
[TBL] [Abstract][Full Text] [Related]
53. [Gene therapy for ischemic stroke].
Abe K
Brain Nerve; 2008 Nov; 60(11):1373-81. PubMed ID: 19069172
[TBL] [Abstract][Full Text] [Related]
54. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
[TBL] [Abstract][Full Text] [Related]
55. The change of the neuron-glia differentiation rate in human neural precursor cells (HPCs) and Ad-BDNF-/-GDNF-infected HPCs following the administration of a neurotoxin.
Yoo YM; Kim YJ; Lee U
Neurosci Lett; 2005 Oct; 387(2):100-4. PubMed ID: 16081212
[TBL] [Abstract][Full Text] [Related]
56. [Gene therapy and neurotrophic factor treatment for amyotrophic lateral sclerosis].
Abe K; Manabe Y; Murakami T
Rinsho Shinkeigaku; 2001 Dec; 41(12):1160-1. PubMed ID: 12235826
[TBL] [Abstract][Full Text] [Related]
57. Adenovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cell loss after transient cochlear ischemia in gerbils.
Hakuba N; Watabe K; Hyodo J; Ohashi T; Eto Y; Taniguchi M; Yang L; Tanaka J; Hata R; Gyo K
Gene Ther; 2003 Mar; 10(5):426-33. PubMed ID: 12601397
[TBL] [Abstract][Full Text] [Related]
58. A comparison of the effects of glial cell line-derived neurotrophic factor on spinal cord and cortex cerebri grafts.
Trok K; Almström S; Olson L
J Pharmacol Exp Ther; 1996 Aug; 278(2):941-9. PubMed ID: 8768751
[TBL] [Abstract][Full Text] [Related]
59. Human umbilical cord blood-derived CD34+ cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors.
Kao CH; Chen SH; Chio CC; Lin MT
Shock; 2008 Jan; 29(1):49-55. PubMed ID: 17666954
[TBL] [Abstract][Full Text] [Related]
60. In vitro non-viral lipofectamine delivery of the gene for glial cell line-derived neurotrophic factor to human umbilical cord blood CD34+ cells.
Yu G; Borlongan CV; Ou Y; Stahl CE; Yu S; Bae E; Kaneko Y; Yang T; Yuan C; Fang L
Brain Res; 2010 Apr; 1325():147-54. PubMed ID: 20171195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
